Why Profusa Stands Out in Small-Cap Investing Profusa (NASDAQ: PFSA) is a biotech company that is developing tissue‑integrating biosensors for…
Read More »Tempest Therapeutics
Tempest Therapeutics (NASDAQ: TPST), a clinical-stage biotechnology firm focused on innovative cancer therapies, announced a significant milestone on Thursday as…
Read More »